» Articles » PMID: 37414902

A Comprehensive Review on Human Disease-causing Bacterial Proteases and Their Impeding Agents

Overview
Journal Arch Microbiol
Specialty Microbiology
Date 2023 Jul 6
PMID 37414902
Authors
Affiliations
Soon will be listed here.
Abstract

Proteases are enzymes that catalyze the amide bond dissociation in polypeptide and protein peptide units. They are categorized into seven families and are responsible for a wide spectrum of human ailments, such as various types of cancers, skin infections, urinary tract infections etc. Specifically, the bacterial proteases cause a huge impact in the disease progression. Extracellular bacterial proteases break down the host defense proteins, while intracellular proteases are essential for pathogens virulence. Due to its involvement in disease pathogenesis and virulence, bacterial proteases are considered to be potential drug targets. Several studies have reported potential bacterial protease inhibitors in both Gram-positive and Gram-negative disease causing pathogens. In this study, we have comprehensively reviewed about the various human disease-causing cysteine, metallo, and serine bacterial proteases as well as their potential inhibitors.

Citing Articles

Apo-Lactoferrin Inhibits the Proteolytic Activity of the 110 kDa Zn Metalloprotease Produced by A2.

Ramirez-Rico G, Ruiz-Mazon L, Reyes-Lopez M, Rivillas Acevedo L, Serrano-Luna J, de la Garza M Int J Mol Sci. 2024; 25(15).

PMID: 39125801 PMC: 11311601. DOI: 10.3390/ijms25158232.


Cleavage of cell junction proteins as a host invasion strategy in leptospirosis.

Kumari P, Yadav S, Sarkar S, Satheeshkumar P Appl Microbiol Biotechnol. 2024; 108(1):119.

PMID: 38204132 PMC: 10781872. DOI: 10.1007/s00253-023-12945-y.

References
1.
Basha S, Rai P, Poon V, Saraph A, Gujraty K, Go M . Polyvalent inhibitors of anthrax toxin that target host receptors. Proc Natl Acad Sci U S A. 2006; 103(36):13509-13. PMC: 1569193. DOI: 10.1073/pnas.0509870103. View

2.
Berggren K, Johansson B, Fex T, Kihlberg J, Bjorck L, Luthman K . Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant. Bioorg Med Chem. 2009; 17(9):3463-70. DOI: 10.1016/j.bmc.2009.03.026. View

3.
Berggren K, Vindebro R, Bergstrom C, Spoerry C, Persson H, Fex T . 3-aminopiperidine-based peptide analogues as the first selective noncovalent inhibitors of the bacterial cysteine protease IdeS. J Med Chem. 2012; 55(6):2549-60. PMC: 3310199. DOI: 10.1021/jm201517a. View

4.
Bhandari V, Wong K, Zhou J, Mabanglo M, Batey R, Houry W . The Role of ClpP Protease in Bacterial Pathogenesis and Human Diseases. ACS Chem Biol. 2018; 13(6):1413-1425. DOI: 10.1021/acschembio.8b00124. View

5.
Bhattacharya A, Rana K, Raut D, Mhaindarkar V, Khan M . An efficient synthesis of benzodiazepinyl phosphonates as clostripain inhibitors via FeCl3 catalyzed four-component reaction. Org Biomol Chem. 2011; 9(15):5407-13. DOI: 10.1039/c0ob01102a. View